Brought to you by 
Abbott and Takeda end TAP joint venture after 30 years
27 Mar 2008
Executive Summary
Ending one of the most lucrative joint ventures in US pharma history, Abbott and Takeda have decided to conclude the operations of TAP Pharmaceutical Products and evenly divide its assets.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Joint Venture
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott and Takeda end TAP joint venture after 30 years
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice